Published in Am J Cardiovasc Dis on July 25, 2012
Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol (2015) 1.11
The emerging role of neutrophils in thrombosis-the journey of TF through NETs. Front Immunol (2012) 0.98
Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World J Gastroenterol (2014) 0.96
Behçet's Disease, Associated Large Vessel Thrombosis, and Coexistent Thrombophilia: A Distinct Nosological Entity? Case Rep Med (2013) 0.89
Risk of venous thromboembolism in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2013) 0.87
Procoagulatory state in inflammatory bowel diseases is promoted by impaired intestinal barrier function. Gastroenterol Res Pract (2015) 0.83
Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees. Thromb Res (2014) 0.82
Comparison of venous thromboembolism after total hip arthroplasty between ankylosing spondylitis and osteoarthritis. Biomed Res Int (2014) 0.78
Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases. J Thromb Thrombolysis (2014) 0.76
Thrombotic processes in multiple sclerosis as manifestation of innate immune activation. Front Neurol (2014) 0.76
Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: A UNOS database analysis. BMC Anesthesiol (2016) 0.75
Venous thrombosis of sarcoidosis as an unusual incidental finding on 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Indian J Nucl Med (2015) 0.75
Are microparticles the missing link between thrombosis and autoimmune diseases? Involvement in selected rheumatologic diseases. Semin Thromb Hemost (2014) 0.75
Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation. Curr Med Chem (2016) 0.75
A Case of Miller Fisher Syndrome, Thromboembolic Disease, and Angioedema: Association or Coincidence? Am J Case Rep (2017) 0.75
Comparison of Venous Thromboembolism after Total Artificial Joint Replacement between Musculoskeletal Tumors and Osteoarthritis of the Knee by a Single Surgeon. PLoS One (2016) 0.75
Idiopathic inflammatory myopathy and the risk of venous thromboembolism: a meta-analysis. Rheumatol Int (2017) 0.75
Inflammation in atherosclerosis. Nature (2002) 28.92
Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature (1994) 9.06
Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet (1999) 8.44
The family history--more important than ever. N Engl J Med (2004) 8.35
The epidemiology of venous thromboembolism. Circulation (2003) 6.97
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med (1999) 6.88
Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med (2011) 5.86
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet (2010) 5.63
Venous thrombosis: a multicausal disease. Lancet (1999) 5.41
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A (1993) 4.57
Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) (2003) 4.00
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation (2004) 3.83
Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet (2007) 3.66
An association between atherosclerosis and venous thrombosis. N Engl J Med (2003) 3.39
Vascular complications of inflammatory bowel disease. Mayo Clin Proc (1986) 3.00
Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet (2006) 2.94
The interactions between inflammation and coagulation. Br J Haematol (2005) 2.92
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet (2006) 2.72
Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut (2004) 2.55
Management of antiphospholipid antibody syndrome: a systematic review. JAMA (2006) 2.47
Antiphospholipid syndrome. Lancet (2010) 2.47
Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med (2011) 2.32
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost (2006) 2.32
The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost (2001) 2.31
Behçet's syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol (2007) 2.29
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet (2011) 2.12
Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol (2008) 2.09
Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost (2006) 1.98
Evolution of enzyme cascades from embryonic development to blood coagulation. Trends Biochem Sci (2002) 1.96
The role of microparticles in inflammation and thrombosis. Scand J Immunol (2007) 1.93
Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med (2011) 1.89
The epidemiology of venous thromboembolism in the community. Thromb Haemost (2001) 1.86
A prospective study on cardiovascular events after acute pulmonary embolism. Eur Heart J (2004) 1.80
Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med (2004) 1.79
Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis. Lancet (1994) 1.78
Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation (2011) 1.73
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut (2011) 1.70
Brief report: autoimmune protein S deficiency in a boy with severe thromboembolic disease. N Engl J Med (1993) 1.68
Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol (2011) 1.67
Risk for incident arterial or venous vascular events varies over the course of systemic lupus erythematosus. J Rheumatol (2006) 1.65
Basic mechanisms and pathogenesis of venous thrombosis. Blood Rev (2009) 1.62
Genetics of venous thrombosis. J Thromb Haemost (2009) 1.54
Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest (1994) 1.54
Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood (2008) 1.51
Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol (1998) 1.45
Protein C anticoagulant system--anti-inflammatory effects. Semin Immunopathol (2011) 1.45
Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One (2011) 1.43
Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation (2003) 1.43
Anti-prothrombin antibodies are associated with thrombosis in children. Thromb Res (2009) 1.40
Inflammation, innate immunity and blood coagulation. Hamostaseologie (2010) 1.39
Mechanistic view of risk factors for venous thromboembolism. Arterioscler Thromb Vasc Biol (2012) 1.33
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest (2007) 1.32
Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: the Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study. Ann Intern Med (2005) 1.30
Acute infections and venous thromboembolism. J Intern Med (2011) 1.30
Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol (2011) 1.27
Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol (2002) 1.20
Thrombophlebitis in systemic lupus erythematosus. JAMA (1978) 1.18
Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost (2009) 1.17
Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br J Haematol (2010) 1.16
Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol (2007) 1.13
Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol (2000) 1.12
Epidemiology and incidence: the scope of the problem and risk factors for development of venous thromboembolism. Clin Chest Med (2010) 1.12
High dose dexamethasone increases circulating P-selectin and von Willebrand factor levels in healthy men. Thromb Haemost (2005) 1.11
Thrombotic risk factors: basic pathophysiology. Crit Care Med (2010) 1.10
Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Nat Rev Rheumatol (2010) 1.08
Epidemiology of connective tissue disorders. Rheumatology (Oxford) (2006) 1.08
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients. Arthritis Rheum (2005) 1.05
The value of family history as a risk indicator for venous thrombosis. Arch Intern Med (2009) 1.04
What is antiphospholipid syndrome? Curr Rheumatol Rep (2004) 1.02
Venous thromboembolism and atherosclerosis: common denominators or different diseases? J Thromb Haemost (2006) 1.02
Coagulation systems of invertebrates and vertebrates and their roles in innate immunity: the same side of two coins? J Innate Immun (2010) 1.01
Increased risk of pulmonary embolism among patients with hyperthyroidism: a 5-year follow-up study. J Thromb Haemost (2010) 1.01
Prevalence of the antiphospholipid syndrome in primary systemic vasculitis. Ann Rheum Dis (2006) 1.00
The link between vascular features and thrombosis. Annu Rev Physiol (2011) 0.99
Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost (2005) 0.98
Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors. J Thromb Haemost (2010) 0.97
Thrombosis in systemic lupus erythematosus and other autoimmune diseases of recent onset. J Rheumatol (2009) 0.97
Thrombophilia as a multigenic disease. Haematologica (1999) 0.97
Role of the protein C pathway in the extraintestinal thrombosis associated with murine colitis. Gastroenterology (2008) 0.97
The role of inflammation in venous thromboembolism and the link between arterial and venous thrombosis. Int Angiol (2007) 0.96
Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. PLoS One (2012) 0.94
Rheumatoid arthritis: a risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis. J Orthop Sci (2010) 0.92
Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol (2007) 0.92
Thrombophilia testing in patients with venous thromboembolism. Findings from the RIETE registry. Thromb Res (2008) 0.92
Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost (2012) 0.91
Acquired free protein S deficiency is associated with antiphospholipid antibodies and increased thrombin generation in patients with systemic lupus erythematosus. Am J Med (1995) 0.91
Myocardial infarction associated with homozygous resistance to activated protein C. Lancet (1994) 0.91
Prevalence of anti-protein S antibodies in patients with systemic lupus erythematosus. Arthritis Rheum (2000) 0.90
Socioeconomic and occupational risk factors for venous thromboembolism in Sweden: a nationwide epidemiological study. Thromb Res (2011) 0.88
Thrombosis as a complication of inflammatory bowel disease in children: a report of four cases. J Pediatr Gastroenterol Nutr (1985) 0.88
Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis (2011) 0.87
Challenges in the diagnosis of the antiphospholipid syndrome. Clin Chem (2010) 0.87
Incidence rates of arterial and venous thrombosis after diagnosis of systemic lupus erythematosus. Arthritis Rheum (2005) 0.87
Thrombosis in systemic lupus erythematosus. Semin Thromb Hemost (2009) 0.85
Risk of thromboembolism in 14,000 individuals with coeliac disease. Br J Haematol (2007) 0.84
Urbanisation and incidence of psychosis and depression: follow-up study of 4.4 million women and men in Sweden. Br J Psychiatry (2004) 4.94
Gestational age at birth and mortality in young adulthood. JAMA (2011) 3.31
Identification of population subgroups of children and adolescents with high asthma prevalence: findings from the Third National Health and Nutrition Examination Survey. Arch Pediatr Adolesc Med (2002) 2.38
Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden. Lancet Oncol (2012) 2.32
Site-specific survival rates for cancer of unknown primary according to location of metastases. Int J Cancer (2013) 2.24
Mental disorders and vulnerability to homicidal death: Swedish nationwide cohort study. BMJ (2013) 2.16
Cancer risks in first-generation immigrants to Sweden. Int J Cancer (2002) 2.16
Inequities in CHD incidence and case fatality by neighborhood deprivation. Am J Prev Med (2007) 2.16
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet (2011) 2.12
Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics (2008) 2.11
Familial renal cell carcinoma from the Swedish Family-Cancer Database. Eur Urol (2011) 2.10
Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood (2004) 2.05
IQ and schizophrenia in a Swedish national sample: their causal relationship and the interaction of IQ with genetic risk. Am J Psychiatry (2014) 2.05
Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry (2013) 2.03
Mesothelioma is a killer of urban men in Sweden. Int J Cancer (2003) 2.02
Genetic and familial environmental influences on the risk for drug abuse: a national Swedish adoption study. Arch Gen Psychiatry (2012) 2.00
Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol (2009) 1.95
Neighborhood deprivation and cardiovascular disease risk factors: protective and harmful effects. Scand J Public Health (2006) 1.85
Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients. Circulation (2012) 1.82
Genetic and family and community environmental effects on drug abuse in adolescence: a Swedish national twin and sibling study. Am J Psychiatry (2014) 1.82
Do immigrants have an increased prevalence of unhealthy behaviours and risk factors for coronary heart disease? Eur J Cardiovasc Prev Rehabil (2005) 1.79
Risk of cancer following hospitalization for type 2 diabetes. Oncologist (2010) 1.75
Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation (2011) 1.73
Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. Arthritis Rheum (2009) 1.73
Neighborhood violent crime and unemployment increase the risk of coronary heart disease: a multilevel study in an urban setting. Soc Sci Med (2005) 1.65
Familial aggregation of Hodgkin lymphoma and related tumors. Cancer (2004) 1.60
Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost (2013) 1.50
Low-linking social capital as a predictor of mental disorders: a cohort study of 4.5 million Swedes. Soc Sci Med (2006) 1.50
Preterm birth and risk of medically treated hypothyroidism in young adulthood. Clin Endocrinol (Oxf) (2011) 1.48
Shared familial aggregation of susceptibility to autoimmune diseases. Arthritis Rheum (2009) 1.45
Gestational age at birth and risk of testicular cancer. Int J Cancer (2011) 1.45
Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev (2005) 1.45
Low linking social capital as a predictor of coronary heart disease in Sweden: a cohort study of 2.8 million people. Soc Sci Med (2005) 1.42
The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int J Cancer (2010) 1.42
Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start? Breast Cancer Res Treat (2009) 1.42
Gender effects in familial cancer. Int J Cancer (2002) 1.41
Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry (2013) 1.40
Effect of cardiovascular drugs on mortality in atrial fibrillation and chronic heart failure. Scand Cardiovasc J (2014) 1.40
Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer (2003) 1.39
Morbidity and mortality risk among patients with screening-detected severe hypertension in the Malmö Preventive Project. J Hypertens (2014) 1.39
Ethnicity, acculturation, and self reported health. A population based study among immigrants from Poland, Turkey, and Iran in Sweden. J Epidemiol Community Health (2004) 1.39
Mortality causes in cancer patients with type 2 diabetes mellitus. Eur J Cancer Prev (2012) 1.39
Cancer risks in second-generation immigrants to Sweden. Int J Cancer (2002) 1.33
Tumor location and patient characteristics of colon and rectal adenocarcinomas in relation to survival and TNM classes. BMC Cancer (2010) 1.30
Physical activity, exercise and self-rated health: a population-based study from Sweden. BMC Public Health (2008) 1.26
Within-family environmental transmission of drug abuse: a Swedish national study. JAMA Psychiatry (2013) 1.20
Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. Eur Urol (2010) 1.18
Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. Schizophr Bull (2012) 1.18
Risk of hypertension among young adults who were born preterm: a Swedish national study of 636,000 births. Am J Epidemiol (2011) 1.18
Familial risks in nervous system tumors. Cancer Epidemiol Biomarkers Prev (2003) 1.17
Familial risk of cancer by site and histopathology. Int J Cancer (2003) 1.15
The long-term effect of physical activity on incidence of coronary heart disease: a 12-year follow-up study. Prev Med (2004) 1.15
Women, international migration and self-reported health. A population-based study of women of reproductive age. Soc Sci Med (2003) 1.15
Cancer risks in ulcerative colitis patients. Int J Cancer (2008) 1.15
Risk of asthma in young adults who were born preterm: a Swedish national cohort study. Pediatrics (2011) 1.14
The influences of place of birth and socioeconomic factors on attempted suicide in a defined population of 4.5 million people. Arch Gen Psychiatry (2003) 1.13
Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma. Cancer (2003) 1.12
Physical activity and concordance between objective and perceived walkability. Med Sci Sports Exerc (2012) 1.12
Familial risks for type 2 diabetes in Sweden. Diabetes Care (2009) 1.10
Neighborhood deprivation and psychiatric medication prescription: a Swedish national multilevel study. Ann Epidemiol (2011) 1.10
Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer (2012) 1.09